Not Yet Recruiting
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
NCT07268612
- Conditions
- Anthrax, Bacillaceae Infections, Bacterial Infections, +6 more
- Locations
-
Not specified